Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.

@article{Chan2004LipoproteinTI,
  title={Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.},
  author={Dick C. Chan and Peter Hugh R Barrett and Gerald F. M. Watts},
  journal={Clinical science},
  year={2004},
  volume={107 3},
  pages={221-32}
}
The metabolic syndrome encapsulates visceral obesity, insulin resistance, diabetes, hypertension and dyslipidaemia. Dyslipidaemia is a cardinal feature of the metabolic syndrome that accelerates the risk of cardiovascular disease. It is usually characterized by high plasma concentrations of triacylglycerol (triglyceride)-rich and apoB (apolipoprotein B)-containing lipoproteins, with depressed concentrations of HDL (high-density lipoprotein). However, lipoprotein metabolism is complex and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 72 references

, and prevalence of coronary heart disease among NHANES III participants age 50 years and older

D. C. Chan, P. H. R. Barrett, G. F. Watts
2004

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

H. B. Bewer
Arterioscler., Thromb., Vasc. Biol • 2004

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

P. M. Gorter, J. K. Olijhoek, +3 authors F.L.J. Visseren
Atherosclerosis • 2004

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994

M. R. Carnethon, S. B. Heymsfield
Arch. Intern. Med • 2003

Similar Papers

Loading similar papers…